These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6226337)

  • 1. The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue.
    Harms HH
    Brain Res; 1983 Sep; 275(1):99-104. PubMed ID: 6226337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
    Mongeau R; De Montigny C; Blier P
    Eur J Pharmacol; 1994 Dec; 271(1):121-9. PubMed ID: 7698195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment.
    Marcusson J; Bäckström IT; Ross SB
    Psychopharmacology (Berl); 1988; 94(2):193-6. PubMed ID: 2965397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo.
    Pawłowski L; Mazela H
    J Pharm Pharmacol; 1984 Dec; 36(12):855-8. PubMed ID: 6151986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-Noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment.
    Schoffelmeer AN; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):173-80. PubMed ID: 6278332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of selectivity between the uptake of [3H]adrenaline and [3H]noradrenaline into rat hypothalamic slices.
    Routledge C; Marsden CA
    J Neurochem; 1987 Sep; 49(3):821-7. PubMed ID: 3497226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments.
    Cheetham SC; Viggers JA; Butler SA; Prow MR; Heal DJ
    Neuropharmacology; 1996 Jan; 35(1):63-70. PubMed ID: 8684598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex.
    Hughes ZA; Stanford SC
    Eur J Pharmacol; 1996 Dec; 317(1):83-90. PubMed ID: 8982723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antidepressant drugs on macrophage cytotoxic activity in rats.
    Belowski D; Kowalski J; Madej A; Herman ZS
    Pol J Pharmacol; 2004; 56(6):837-42. PubMed ID: 15662098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of noradrenaline transporters in S-nitrosocysteine-stimulated noradrenaline release from rat brain slices: existence of functional Na(+)-independent transporter activity.
    Maekawa M; Murayama T; Nomura Y
    Neurochem Int; 2001 Apr; 38(4):323-31. PubMed ID: 11137627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of presynaptic components (uptake--release) in antidepressants].
    Dolzhenko AT
    Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
    Mann CD; Vu TB; Hrdina PD
    Br J Pharmacol; 1995 Jun; 115(4):595-600. PubMed ID: 7582477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
    Wong DT; Bymaster FP; Reid LR; Threlkeld PG
    Biochem Pharmacol; 1983 Apr; 32(7):1287-93. PubMed ID: 6303355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
    Zhao Y; Zhang HT; O'Donnell JM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):246-53. PubMed ID: 12954819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the animal pharmacology and pharmacokinetics of fluvoxamine.
    Claassen V
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):349S-355S. PubMed ID: 6407497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.